4//SEC Filing
Watkins Raymond E. 4
Accession 0000891839-20-000051
CIK 0001205922other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:23 PM ET
Size
11.8 KB
Accession
0000891839-20-000051
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Watkins Raymond E.
SVP & Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-25+8,000→ 8,000 totalExercise: $6.07Exp: 2030-02-24→ Common Stock (8,000 underlying)
Holdings
- 28,169
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (28,169 underlying) - 8,635
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (8,635 underlying) - 4,617
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (4,617 underlying) - 7,850
Common Stock
- 8,000
Stock Option (Right to Buy)
Exercise: $3.90Exp: 2029-03-14→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747774
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:23 PM ET
- Size
- 11.8 KB